TrialJCI insight2019

Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes.

Kevan C Herold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.